Trader consensus on Polymarket reflects an 88.5% implied probability of no new pandemic in 2026, driven by the World Health Organization's (WHO) strict criteria for declaration—a novel pathogen with sustained human-to-human transmission and global spread—absent to date despite vigilant surveillance. Recent developments, including WHO's April 7 release of R&D roadmaps for priority pathogen families like influenza and mpox, highlight proactive global preparedness amid ongoing localized threats such as U.S. measles outbreaks nearing 1,700 cases and emerging SARS-CoV-2 variant BA.3.2 ("Cicada"), neither qualifying as novel pandemics per official epidemiological standards from WHO and CDC. Heightened monitoring of H5N1 avian influenza and Oropouche virus persists, but containment measures and historical rarity (last declaration: COVID-19 in 2020) underpin this sentiment, with quarterly WHO updates expected to influence future odds.